Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04940663 · ClinicalTrials.gov registry record · NA

Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness

A NA study of Schizophrenia and Psychosis, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT04940663 is a NA study of Schizophrenia and Psychosis that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04940663, a NA study of Schizophrenia and Psychosis, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The proposed research will test the hypothesis that objective social isolation and loneliness are linked to neurobehavioral mechanisms involved in social perception and motivation in individuals with and without serious mental illness. Moreover, it will investigate the specific dynamic interactions among these experiences in daily life and how they, and their neurobehavioral predictors, are linked to day-to-day functioning. The findings of this project could provide novel targets for therapeutics aimed at improving functioning and overall quality of life in individuals with serious mental illnesses, as well as quantitative phenotypes for use in early detection efforts.

Conditions Studied

Interventions

  • BEHAVIORAL EMA

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-07-13
Est. Completion 2026-06
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04940663

The ClinicalTrials.gov registry entry for NCT04940663 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (45% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which EMA is the first listed.

NCT04940663 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04940663 about?

NCT04940663 is a clinical study titled "Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness". The proposed research will test the hypothesis that objective social isolation and loneliness are linked to neurobehavioral mechanisms involved in social perception and motivation in individuals with and without serious mental illness. Moreover, it will investigate the specific dynamic interactions ...

What is the current status of trial NCT04940663?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-07-13. Estimated completion is 2026-06.

What conditions does trial NCT04940663 study?

This clinical trial studies the following conditions: Schizophrenia, Psychosis.

What interventions are being tested in trial NCT04940663?

The interventions under investigation include: EMA (BEHAVIORAL).

Who is sponsoring clinical trial NCT04940663?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04940663 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.